Jennifer Michaelson. Preclinical Assessment of JTX-2011, an Agonist Antibody Targeting ICOS, Supports Evaluation in ICONIC Clinical Trial. Presented at the AACR Annual Meeting, April 2, 2017.
Contact Us
Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge, MA 02139
Phone: (857) 259-3840
Fax: (888) 459-2940
For Investor and Media inquiries, please contact:
Eric Laub
(857) 259-3853 elaub@jouncetx.com